Abstract
Cyclin-dependent kinase 9 (cdk9) is a multifunctional kinase with roles in different cellular pathways such as transcriptional elongation, differentiation and apoptosis. Cdk9/cyclin T differs functionally from other cdk/cyclin complexes that regulate cell cycle progression, but maintains structural affinity with those complexes. In addition, previous reports have demonstrated that the cdk9 complex is able to phosphorylate p56/pRb in vitro. In this report we show in vitro and in vivo interaction between cdk9/cyclinT2 and the protein product of the retinoblastoma gene (pRb) in human cell lines. The interaction involves the region composed of residues 129–195 of cdk9, cyclinT2 (1–642 aa) and the C-terminal domain of pRb (835–928 aa). We located the minimal region of cdk9 phosphorylation on the C-terminus of pRb, by identifying the residues between 793 and 834. This region contains at least three proline-directed serines (sp), S795, S807 and S811, which have been reported to be phosphorylated in vivo and which could be targeted by the cdk9 complex. These data suggest that, in logarithmically growing cells, cdk9/cyclin T2 and pRb are located in a nuclear multiprotein complex probably involved in transduction of cellular signals to the basal transcription machinery and that one of these signals could be the cdk9 phosphorylation of pRb.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- cdk:
-
cyclin-dependent kinase
- GST:
-
glutathione S-transferase
- pRb:
-
retinoblastoma protein
References
Adams PD, Li X, Sellers WR, Baker KB, Leng X, Harper JW, Taya Y, Kaelin WG . 1999 Mol. Cell. Biol. 19: 1068–1080
Bagella L, MacLachlan TK, Buono RJ, Pisano MM, Giordano A, De Luca A . 1998 J. Cell. Physiol. 177: 206–213
Bagella L, Stiegler P, De Luca A, Siracusa LD, Giordano A . 2000 J. Cell. Biochem. 78: 170–178
Corbeil H, Whyte P, Branton P . 1995 Oncogene 11: 909–920
Dahmus ME . 1996 J. Biol. Chem. 271: 19009–19012
DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huand CM, Lee WH, Marsilio E, Paucha E, Livingston DM . 1998 Cell 54: 257–283
De Falco G, Giordano A . 1998 J. Cell. Physiol. 177: 501–506
De Falco G, Giordano A . 2002 Cancer Biology and Therapy in press
De Falco G, Bagella L, Claudio PP, De Luca A., Fu Y, Calabretta B, Sala A, Giordano A . 2000 Oncogene 19: 373–379
De Luca A, Esposito V, Baldi A, Claudio PP, Fu Y, Caputi M, Pisano M, Baldi F, Giordano A . 1997 J. Cell. Physiol. 172: 265–273
De Luca P, Majello B, Lania L . 1998 J. Cell Biochem. 70: 281–287
Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg R . 1993 Cell 73: 499–511
Edwards MC, Wong C, Elledge SJ . 1998 Mol. Cell. Biol. 18: 4291–4300
Ezhevsky S, Naggahara H, Vocero-Akbani A, Gius D, Wei M, Dowdy S . 1997 Proc. Natl. Acad. Sci. USA 94: 10699–10704
Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J-Y, Livingston . 1993 Cell 73: 487–497
Fanciulli M, Bruno T, Di Padova M, De Angelis R, Iezzi S, Iacobini C, Floridi A, Passananti C . 2000 FASEB J. 14: 904–912
Foskett SM, Ghose R, Tang DN, Lewis DE, Rice AP . 2001 J. Virol. 75: 1220–1228
Grana X, De Luca A, Sang N, Fu Y, Claudio PP, Rosenblatt J, Morgan DO, Giordano A . 1994 Proc. Natl. Acad. Sci. 91: 3834–3838
Gu W, Schneider JW, Condorelli G, Kaushal S, Mahadavi S, Nadal-Ginard B . 1993 Cell 72: 309–324
Hatakeyama M, Brill J, Fink G, Weinberg R . 1994 Genes Dev. 8: 1759–1771
Hollingsworth RE, Hensey CE, Lee W-H . 1993 Curr. Opin. Cell. Biol. 3: 55–62
Kanazawa S, Okamoto T, Peterlin BM . 2000 Immunity 12: 61–70
Kwak YT, Ivanov D, Guo J, Nee E, Gaynor RB . 1999 J. Mol. Biol. 288: 57–69
Lee O-J, Russo AA, Pavletich NP . 1998 Nature 391: 859–865
Lis JT, Mason P, Peng J, Price DH, Werner J . 2000 Genes Dev. 11: 2633–2644
Lundberg AS, Weinberg RA . 1998 Mol. Cell. Biol. 18: 753–761
MacLachlan TK, Sang N, Giordano A . 1995 Crit. Rew. Eukariot. Gene Expr. 5: 127–156
Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A . 1998 Nature 391: 601–605
Mancebo H, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Blau C, Hazuda D, Price D, Flores O . 1997 Genes Dev. 11: 2633–2644
Marshall N, Peng J, Xie Z, Price D . 1996 J. Biol. Chem. 271: 27176–27183
Mittnacht S . 1998 Curr. Opin. Genet. Dev. 8: 21–27
Napolitano G, Majello B, Licciardo P, Giordano A, Lania L . 2000 Gene 254: 139–145
Novitch BG, Mulligan GJ, Jacks T, Lassar AB . 1996 J. Cell. Biol. 135: 441–456
Novitch BG, Spicer DB, Kim PS, Cheung WL, Lassar AB . 1999 Curr. Biol. 9: 449–459
Pan W, Sun T, Hoess RH, Grafstrom RH . 1998 Carcinogenesis 19: 765–769
Pan W, Cox S, Hoess RH, Grafstrom RH . 2001 Cancer Res. 61: 2885–2891
Peng J, Zhu Y, Milton JT, Price DH . 1998 Genes Dev. 12: 755–762
Puri PL, Balsano C, Burgio V, Chirillo P, Natoli G, Ricci L, Mattei E, Graessmann A, Levrero M . 1997 Oncogene 14: 1171–1184
Puri PL, Sartorelli V . 2000 J. Cell. Physiol. 185: 155–173
Qian Y, Luckey C, Horton L, Esser M, Templeton DJ . 1992 Mol. Cell. Biol. 12: 5363–5372
Schneider J, Gu W, Zhu L, Mahdavi V, Nadal-Ginard B . 1994 Science 264: 1467–1471
Shin E, Shin A, Paulding C, Schaffhausen B, Yee A . 1995 Mol. Cell. Biol. 15: 2252–2262
Simone C, Giordano A . 2001 Frontiers in Bioscience 6: 1073–1082
Simone C, Stiegler P, Bagella L, Pucci B, Bellan C, De Falco G, De Luca A, Guanti G, Puri PL, Giordano A . 2002 Oncogene 21: 4137–4148
Stiegler P, Giordano A . 2001 Crit. Rev. Eukariot. Gene Expr. 11: 59–76
Wei P, Gender ME, Fang SM, Fisher WH, Jones KA . 1998 Cell 92: 451–462
Welch PJ, Wang JYJ . 1993 Cell 75: 779–790
Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E . 1988 Nature 334: 124–129
Wimmer J, Fujinaga K, Taube R, Cujec TP, Zhu Y, Peng J, Price DH, Peterlin BM . 1999 Virology 255: 182–189
Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR, Livingston DM . 1995 Nature 375: 694–698
Yang X, Hermann HC, Rice AP . 1996 J. Virol. 70: 4576–4584
Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews M, Price D . 1997 Genes Dev. 11: 2622–2632
Acknowledgements
We thank Marie Basso for her editorial assistance in the preparation of the manuscript and Dr Gaia Gallo for her technical support. We thank Dr David Price for generously providing reagents. This work was supported in part by grants from the Sbarro Institute for Cancer Research and Molecular Medicine (to Dr Giordano). Drs Bellan and Bagella are supported by a ‘Dottorato di Ricerca in Patologia Diagnostica Quantitativa’ from the University of Siena. Finally, we thank Letizia Lavermicocca for her encouragement and support. We dedicate this work to the memory of Professor Angelo Carbonara.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Simone, C., Bagella, L., Bellan, C. et al. Physical interaction between pRb and cdk9/cyclinT2 complex. Oncogene 21, 4158–4165 (2002). https://doi.org/10.1038/sj.onc.1205511
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205511
Keywords
This article is cited by
-
Characteristics and mechanisms of latency-reversing agents in the activation of the human immunodeficiency virus 1 reservoir
Archives of Virology (2023)
-
MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2
International Journal of Hematology (2017)
-
Cyclin-dependent kinases regulate apoptosis of intestinal epithelial cells
Apoptosis (2014)
-
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs
Leukemia (2013)
-
Induced G1 cell-cycle arrest controls replication-dependent histone mRNA 3′ end processing through p21, NPAT and CDK9
Oncogene (2010)